A Study of SLV-154 in People With Solid Tumor Cancer

Full Title

A Phase 1 Dose-Escalation Study of SLV-154 in Subjects with Metastatic Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Roisin O’Cearbhaill’s office at 646-888-4227.

Protocol
25-316
Phase
Phase I (phase 1)
Disease Status
Relapsed or Refractory
Investigator
Roisin E. O'Cearbhaill
Co-Investigators
Paul Sabbatini
Diseases
Endometrial and other Uterine Cancers › Endometrial Cancer
Gynecologic Cancer › Cervical Cancer
Gynecologic Cancer › Ovarian Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06771219
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description